Mirakof SR Tablet
by Square Pharmaceuticals Limited
৳10.00
Sharif Pharmaceuticals Ltd.
Bucod SR 50mg tablet from Sharif Pharmaceuticals & Generic is Butamirate Citrate 50mg. Butamirate Citrate is used to relieve dry (non-productive) cough. Dry cough may be caused by a recent viral infection. It is also used for pre- & post-operative cough sedation in patients who will undergo surgical procedures and bronchoscopy. It can be used in acute cough of any etiology, whooping cough and cough due to acute lower respiratory tract infections (tracheitis, laryngitis, bronchitis) etc.
Butamirate Citrate is utilized to calm dry (non-productive) hack. Dry hack may be caused by a later viral contamination. Butamirate Citrate is additionally utilized for pre & post-operative hack sedation in patients who will experience surgical strategies and bronchoscopy. It can be utilized within the intense hack of any etiology, whooping hack and hack due to intense lower respiratory tract contaminations (tracheitis, laryngitis, bronchitis) etc.
Butamirate Citrate acts straightforwardly on the brain's hack center to stifle hack. Butamirate Citrate is secure and non-sedating which is not one or the other chemically nor pharmacologically related to opium alkaloids. Butamirate Citrate is quickly and totally ingested after verbal organization. Most extreme concentration is come to inside 9 hours with the sustained-release tablet. Typically greatly protein-bound and plasma disposal half-life is almost 13 hours. The dynamic metabolites of Butamirate Citrate have moreover antitussive activity.
Use in adult:
Use in children & adolescents:
Butamirate Citrate 50 mg tablet:
Butamirate Citrate syrup:
Butamirate Citrate pediatric drops:
It's best to avoid taking expectorants at the same time.
Intolerance to the active ingredient.
Butamirate Citrate has a high tolerance. In a few rare cases, adverse reactions such as rash, nausea, diarrhoea, and vertigo have been reported, but they have all resolved after the dose was reduced or the treatment was stopped.
During the first trimester of pregnancy, butamirate Citrate should be avoided. It can be used for the rest of the pregnancy if a doctor recommends it, but only with caution. In the absence of data on the active substance's elimination in breast milk, the benefits of Butamirate Citrate administration during breast feeding should be carefully weighed for safety reasons.
In patients with epilepsy (avoid if poorly controlled, discontinue if convulsions develop), concurrent electroconvulsive therapy (prolonged seizures reported with fluoxetine), history of mania, cardiac disease, diabetes mellitus, angle-closure glaucoma, concomitant use of drugs that increase bleeding risk, and history of bleeding disorders, SSRIs should be used with caution.
Cough suppressant
Protect from light and moisture by storing below 30°C. Keep the medicine out of children's reach.
by Delta Pharma Limited
৳10.00